MicroRNA-708-5p Acts as a Therapeutic Agent Against Metastatic Lung Cancer

Oncotarget - United States
doi 10.18632/oncotarget.6594
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

MicroRNA-708 (miR-708)

Science-Business eXchange
2011English

A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer

Science Translational Medicine
Medicine
2012English

The &Ldquo;melanoma-Enriched” microRNA miR-4731-5p Acts as a Tumour Suppressor

Oncotarget
Oncology
2016English

An IL13Rα2 Peptide Exhibits Therapeutic Activity Against Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Metastatic Lung Cancer Presenting as Cutaneous Nodules

CMAJ
Medicine
2017English

Hypnotism as a Therapeutic Agent.

The Lancet
Medicine
1890English

Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities

Nanomaterials
Materials ScienceChemical Engineering
2018English

MicroRNA-155-5p Suppresses PD-L1 Expression in Lung Adenocarcinoma

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2020English

MicroRNA-186 and Metastatic Prostate Cancer.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy